Sale!

PCDH19 Gene Early infantile epileptic encephalopathy type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PCDH19 gene is associated with early infantile epileptic encephalopathy type 9 (EIEE9), a rare genetic disorder primarily affecting females. It is characterized by the onset of seizures in infancy or early childhood, which can be accompanied by developmental delays and cognitive impairments as the condition progresses. The PCDH19 gene plays a crucial role in the development and function of the nervous system, and mutations in this gene are directly linked to the symptoms of EIEE9.

Genetic testing for mutations in the PCDH19 gene is essential for the accurate diagnosis of EIEE9. This testing helps in understanding the genetic basis of the condition, which can guide treatment decisions and provide information on the risk of recurrence in future pregnancies. DNA Labs UAE offers a comprehensive genetic test targeting the PCDH19 gene, providing a reliable diagnosis for families affected by early infantile epileptic encephalopathy type 9.

The cost of the PCDH19 gene test at DNA Labs UAE is 4400 AED. This specialized test is conducted using advanced genetic sequencing technologies to identify mutations in the PCDH19 gene that are responsible for EIEE9. By choosing DNA Labs UAE for this genetic testing, patients and their families can expect accurate results, which are crucial for the management and understanding of this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PCDH19 Gene Early infantile epileptic encephalopathy type 9 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for PCDH19 Gene Early infantile epileptic encephalopathy type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PCDH19 Gene Early infantile epileptic encephalopathy type 9.

Test Details

The PCDH19 gene is associated with Early Infantile Epileptic Encephalopathy type 9 (EIEE9), a rare genetic disorder that affects the brain and causes seizures. The condition primarily affects girls and is caused by mutations in the PCDH19 gene located on the X chromosome. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that analyzes multiple genes simultaneously. This type of testing is useful in identifying mutations in the PCDH19 gene and other genes associated with epilepsy. The PCDH19 gene NGS genetic test involves sequencing the entire coding region of the gene to identify any mutations or variations that may be present. This test can be used to confirm a diagnosis of EIEE9 in individuals with symptoms of the disorder, as well as to identify carriers of the gene mutation in families with a history of the condition. Early diagnosis and treatment of EIEE9 can improve outcomes and quality of life for affected individuals. Genetic testing can also provide valuable information for family planning and genetic counseling.

Test Name PCDH19 Gene Early infantile epileptic encephalopathy type 9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PCDH19 Gene Early infantile epileptic encephalopathy type 9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PCDH19 Gene Early infantile epileptic encephalopathy type 9
Test Details

The PCDH19 gene is associated with Early Infantile Epileptic Encephalopathy type 9 (EIEE9), a rare genetic disorder that affects the brain and causes seizures. The condition primarily affects girls and is caused by mutations in the PCDH19 gene located on the X chromosome.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that analyzes multiple genes simultaneously. This type of testing is useful in identifying mutations in the PCDH19 gene and other genes associated with epilepsy.

The PCDH19 gene NGS genetic test involves sequencing the entire coding region of the gene to identify any mutations or variations that may be present. This test can be used to confirm a diagnosis of EIEE9 in individuals with symptoms of the disorder, as well as to identify carriers of the gene mutation in families with a history of the condition.

Early diagnosis and treatment of EIEE9 can improve outcomes and quality of life for affected individuals. Genetic testing can also provide valuable information for family planning and genetic counseling.